Avanos Financial Statements From 2010 to 2024
| 8HH Stock | EUR 17.60 0.20 1.15% |
Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.
Avanos |
Avanos Medical Company Current Valuation Analysis
Avanos Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Avanos Medical Current Valuation | 1.35 B |
Most of Avanos Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avanos Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Avanos Medical has a Current Valuation of 1.35 B. This is 90.6% lower than that of the Healthcare sector and 85.24% lower than that of the Medical Instruments & Supplies industry. The current valuation for all Germany stocks is 91.88% higher than that of the company.
Avanos Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avanos Medical's current stock value. Our valuation model uses many indicators to compare Avanos Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avanos Medical competition to find correlations between indicators driving Avanos Medical's intrinsic value. More Info.Avanos Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.68 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Avanos Medical is roughly 1.47 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avanos Medical's earnings, one of the primary drivers of an investment's value.About Avanos Medical Financial Statements
Avanos Medical stakeholders use historical fundamental indicators, such as Avanos Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Avanos Medical's assets and liabilities are reflected in the revenues and expenses on Avanos Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Avanos Medical. Please read more on our technical analysis and fundamental analysis pages.
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients quality of life worldwide. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. AVANOS MEDICAL operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4700 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Avanos Stock
When determining whether Avanos Medical is a strong investment it is important to analyze Avanos Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avanos Medical's future performance. For an informed investment choice regarding Avanos Stock, refer to the following important reports:Check out the analysis of Avanos Medical Correlation against competitors. For more detail on how to invest in Avanos Stock please use our How to Invest in Avanos Medical guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.